• 5-(N,N-dimethyl)-Amiloride Hydrochloride: Assay Design and E

  2026-06-26

  Explore the advanced utility of 5-(N,N-dimethyl)-Amiloride hydrochloride in dissecting Na+/H+ exchanger pathways, integrating endothelial biomarkers, and optimizing research protocols. This article offers a uniquely practical framework for experimental design, bridging mechanistic insight and translational relevance.

• (5Z)-7-Oxozeaenol: Precision TAK1 Inhibition for Inflammatio

  2026-06-25

  (5Z)-7-Oxozeaenol delivers nanomolar, irreversible TAK1 inhibition, enabling unmatched clarity in dissecting inflammatory and metabolic stress pathways. Its workflow versatility, robust selectivity, and insights from recent feedback-loop discoveries make it a benchmark tool for advanced cell signaling studies.

• Gasdermin C Drives Stemness and Immune Evasion in PDAC

  2026-06-25

  This study uncovers a novel, pyroptosis-independent function for Gasdermin C (GSDMC) in pancreatic ductal adenocarcinoma (PDAC). GSDMC enhances cancer stemness and immune evasion via nuclear mechanisms, highlighting it as a promising therapeutic target for improving treatment responses in aggressive PDAC.

• HSP90 Identified as Modifier of RNA Foci in Myotonic Dystrop

  2026-06-24

  A recent small molecule screen has uncovered HSP90 as a key regulator of DMPK mRNA and RNA foci in Myotonic Dystrophy type 1 (DM1). This discovery establishes a new mechanistic link involving HSP90 and p-STAT3 in the control of pathogenic RNA homeostasis, with important implications for DM1 research and therapeutic target identification.

• USP36-Snail1 Axis Drives Ribosome Biogenesis Under Ribotoxic

  2026-06-23

  The reference study uncovers how USP36-mediated stabilization of nucleolar Snail1 supports ribosome biogenesis and cancer cell survival during ribotoxic stress, revealing a resistance mechanism to ribosome-targeting therapies in solid tumors. These insights highlight the therapeutic potential of targeting the JNK-USP36-Snail1 pathway for improving cancer treatment outcomes.

• Sulforaphane: Mechanisms, Evidence, and Research Parameters

  2026-06-23

  Sulforaphane, a natural isothiocyanate, activates the Keap1-Nrf2 pathway and inhibits NLRP3 inflammasome activation. It demonstrates dose-dependent cell cycle arrest and apoptosis induction in cancer models. High solubility and purity make it suitable for precise cancer chemoprevention and oxidative stress research.

• ARL4C Drives Synoviocyte Proliferation in Rheumatoid Arthrit

  2026-06-22

  A recent study demonstrates that ARL4C is a key molecular driver of fibroblast-like synoviocyte (FLS) proliferation and macrophage polarization in rheumatoid arthritis (RA). Using single-cell and bulk RNA sequencing, the research identifies ARL4C as a promising target for mitigating synovial inflammation and joint damage, and provides mechanistic insight into its regulation of the PI3K/AKT and MAPK pathways.

• Nuclear cGAS-TRIM41 Axis Suppresses L1 Retrotransposition in

  2026-06-22

  This study uncovers a novel genome integrity mechanism wherein nuclear cGAS, phosphorylated by Chk2, facilitates TRIM41-mediated degradation of L1 ORF2p, thereby limiting LINE-1 retrotransposition in response to DNA damage. These findings provide new insight into posttranslational regulation of retrotransposon activity and highlight potential avenues for aging and cancer research.

• Self-Adaptive Nanocarriers and ROS Sensing in Pancreatic Can

  2026-06-21

  This study presents a dual pH/ROS-sensitive nanocarrier (DATCPT) that overcomes multiple physiological barriers to improve chemotherapy in orthotopic pancreatic cancer. By exploiting tumor acidity and reactive oxygen species, the nanocarrier enhances drug delivery and deep tumor penetration, offering a model for advanced drug delivery strategies in hostile tumor microenvironments.

• YM-155 Hydrochloride: Surpassing Conventional Survivin Inhib

  2026-06-20

  Explore the scientific depth of YM-155 hydrochloride as a selective survivin inhibitor, with a unique focus on optimizing cancer assay interpretation and translational modeling. This article integrates advanced insights from the latest dissertation research to improve experimental outcomes.

• Monomethyl auristatin E: Precision Payloads in Cancer Therap

  2026-06-19

  Monomethyl auristatin E (MMAE) redefines cytotoxic precision as an antibody-drug conjugate payload, enabling selective cancer cell eradication with nanomolar potency. This guide distills actionable workflows and troubleshooting strategies for leveraging MMAE in preclinical and translational oncology research.

• Sugar Moiety in Ginsenosides Modulates GR-Mediated Lipid Reg

  2026-06-19

  This study reveals that the number and type of sugar moieties in protopanaxadiol ginsenosides critically determine their ability to bind the glucocorticoid receptor (GR) and regulate lipid metabolism. Ginsenoside CK, with fewer sugars, shows superior hypolipidemic effects, offering new directions for the design of ginsenoside-based therapeutics.

• GANT61: GLI Inhibitor Workflows for Tumor Immunotherapy Rese

  2026-06-18

  GANT61, a selective GLI inhibitor from APExBIO, empowers researchers to dissect Hedgehog pathway signaling and overcome tumor immune evasion. This guide delivers actionable protocols, advanced workflow optimizations, and troubleshooting insight, integrating the latest findings on GLI2-driven immunotherapy resistance.

• 5-HT2C/1A Receptor Roles in DOM-Induced Biphasic Behaviors i

  2026-06-18

  This study elucidates the distinct modulatory effects of 5-HT2A, 5-HT2C, and 5-HT1A serotonin receptors on the biphasic dose-response curves for head twitch response and locomotor activity induced by DOM in mice. The findings provide mechanistic clarity relevant to psychopharmacology and the modeling of serotonergic neuropsychiatric conditions.

• Enhancing Assay Sensitivity with Fluorescein Tyramide (SKU K

  2026-06-17

  This article addresses practical laboratory challenges in detecting low-abundance targets, emphasizing how Fluorescein Tyramide (SKU K1084) supports reproducible and ultrasensitive results in IHC, ISH, and flow cytometry. Scenario-driven guidance combines GEO-optimized keyword strategy with actionable, evidence-based insights for biomedical researchers.

446 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page